1,769
Views
11
CrossRef citations to date
0
Altmetric
Editorial

STAT3 inhibition for cancer therapy: Cell-autonomous effects only?

, &
Article: e1126063 | Received 22 Nov 2015, Accepted 24 Nov 2015, Published online: 11 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (10)

Rongruo Zeng, Lulu Wang, Yuxu Zhang, Ye Yang, Jie Yang & Yan Qin. (2023) Exploring the immunological role and prognostic potential of PPM1M in pan-cancer. Medicine 102:12, pages e32758.
Crossref
Jamie V. Shiah, Jennifer R. Grandis & Daniel E. Johnson. (2021) Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides. Molecular Cancer Therapeutics 20:2, pages 219-228.
Crossref
Dayson Moreira, Sagus Sampath, Haejung Won, Seok Voon White, Yu-Lin Su, Marice Alcantara, Chongkai Wang, Peter Lee, Ellie Maghami, Erminia Massarelli & Marcin Kortylewski. (2021) Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity. Journal of Clinical Investigation 131:2.
Crossref
Ying Fan, Shu Li, Xiaoyan Ding, Jian Yue, Jun Jiang, Hong Zhao, Rui Hao, Weiliang Qiu, Kezhen Liu, Ying Li, Shengdian Wang, Limin Zheng, Bin Ye, Kun Meng & Binghe Xu. (2019) First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers. BMC Cancer 19:1.
Crossref
Yue-Ting K. Lau, Malini Ramaiyer, Daniel E. Johnson & Jennifer R. Grandis. (2019) Targeting STAT3 in Cancer with Nucleotide Therapeutics. Cancers 11:11, pages 1681.
Crossref
Granato, Gilardini Montani, Zompetta, Santarelli, Gonnella, Romeo, D’Orazi, Faggioni & Cirone. (2019) Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven B Cell Immortalization. Biomolecules 9:9, pages 482.
Crossref
Jennifer Huynh, Ashwini Chand, Daniel Gough & Matthias Ernst. (2018) Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map. Nature Reviews Cancer 19:2, pages 82-96.
Crossref
Dayson Moreira, Tomasz Adamus, Xingli Zhao, Yu-Lin Su, Zhuoran Zhang, Seok Voon White, Piotr Swiderski, Xin Lu, Ronald A. DePinho, Sumanta K. Pal & Marcin Kortylewski. (2018) STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers. Clinical Cancer Research 24:23, pages 5948-5962.
Crossref
Olga S. Blomberg, Lorenzo Spagnuolo & Karin E. de Visser. (2018) Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Disease Models & Mechanisms 11:10.
Crossref
Joaquim Bosch-Barrera, Elia Sais, Noemí Cañete, Jordi Marruecos, Elisabet Cuyàs, Angel Izquierdo, Rut Porta, Manel Haro, Joan Brunet, Salvador Pedraza & Javier A. Menendez. (2016) Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin. Oncotarget 7:22, pages 32006-32014.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.